Comparison of two regimens of weekly paclitaxel plus gemcitabine in patients with metastatic breast cancer: propensity score–matched analysis of real-world data

PURPOSE: Weekly gemcitabine + paclitaxel (wGT) administration is widely applied in real-world clinical practice. The 28-day and 21-day regimens of wGT are the most widely accepted regimens. We evaluated the efficacy and safety of wGT administration in patients with metastatic breast cancer (MBC) and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Chengcheng, Xie, Yizhao, Zhao, Yannan, Li, Yi, Zhang, Jian, Wang, Leiping, Cao, Jun, Tao, Zhonghua, Hu, Xichun, Wang, Biyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793024/
https://www.ncbi.nlm.nih.gov/pubmed/36582188
http://dx.doi.org/10.1177/20420986221146411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793024/
https://www.ncbi.nlm.nih.gov/pubmed/36582188
http://dx.doi.org/10.1177/20420986221146411

Ejemplares similares